Dakla 60 mg (Tablet)
Unit Price: ৳ 400.00 (1 x 7: ৳ 2,800.00)
Strip Price: ৳ 2,800.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Daclatasvir |
| Company | Healthcare pharmaceuticals ltd |
Indications
- Treatment of chronic hepatitis C virus (HCV) infection in adults
Pharmacology
- Direct acting antiviral agent against the Hepatitis C Virus (HCV)
- Inhibitor of NS5A protein
- Inhibits viral RNA replication and virion assembly
Dosage & Administration
- Recommended dose of 60 mg once daily
- Oral administration with or without meals
- Administration in combination with other medicinal products
- Dosage recommendations for different patient groups and concomitant medicines
Interactions
- Substrate of CYP3A
- Effect of moderate or strong inducers/inhibitors of CYP3A on plasma levels
- Inhibitor of P-glycoprotein transporter (P-gp), organic anion transporting polypeptide (OATP) 1B1 and 1B3, and breast cancer resistance protein (BCRP)
Contraindications
- Contraindicated in combination with drugs that strongly induce CYP3A
- Specific drugs that are contraindicated
Side Effects
- Serious symptomatic bradycardia when coadministered with certain drugs
- List of symptoms related to bradycardia
Pregnancy & Lactation
- No data available for pregnant women or breastfeeding mothers
Precautions & Warnings
- Risk of adverse reactions or loss of virologic response due to drug interactions
- Specific warning about symptomatic bradycardia when coadministered with certain drugs and patients counseling
Use in Special Populations
- No dose adjustment required for elderly, renal impairment, or hepatic impairment
- Safety and efficacy in the pediatric population not established
Overdose Effects
- No known antidote for overdose
- General supportive measures for treatment of overdose
Therapeutic Class
- Hepatic viral infections (Hepatitis C)
Storage Conditions
- Store at room temperature below 30°C
- Protect from light
- Keep out of the reach of children